midostaurin
SpainDrugs containing this active substance
-
It is used to treat acute myeloid leukemia (AML) in adults with a FLT3 gene mutation. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematologic neoplasm (SM-AHN), or mast cell leukemia (MCL).
Form: capsules, soft gelatin
Active substance Dosage midostaurin 25,00 mg Manufacturer: Novartis Europharm Limited